CHP Staining: Unlocking a New Therapeutic Strategy for Fibrosis
Fibrosis, the pathological accumulation of collagen and other ECM components, is a major health concern implicated in an estimated ⅓ of all natural deaths. While current anti-fibrotic drugs aim to slow progression, advanced fibrosis is often left untreated, leaving transplantation the only remaining option in many cases. A new therapeutic approach is focusing on...
View Details
Beyond Scar Tissue: Can Understanding Cardiac ECM Remodeling Revolutionize Heart Repair?
Cardiovascular biology has seen significant advances in recent times, yet heart disease remains the leading cause of morbidity & mortality worldwide. A critical challenge following an acute Myocardial Infarction (MI, heart attack) is the irreversible loss of millions of cardiac muscle cells (Cardiomyocytes, CM). These lost cells are replaced by fibrotic scar tissue....
View Details
Collagen Hybridizing Peptides Validate a Novel Bone Organoid Model
Validate collagen integrity in your biomaterials with 3helix CHPs. Discover how Collagen Hybridizing Peptides (CHPs, 3Helix Inc.) ensure reliable data in tissue engineering and bone remodeling research.
View Details



